More information: Laura Martinez-Verbo et al, PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma, Leukemia (2024). DOI: 10.1038/s41375-024-02419-z Provided by Josep ...

While it trails Johnson & Johnson’s Tecvayli, Regeneron still hopes Lynozyfic can differentiate in terms of dosing ...

New epigenetic regulatory mechanisms involved in multiple myeloma growth. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2021 / 05 / 210517102627.htm ...

Meeting Coverage > ASH Video Pearls Using the Epigenetic Landscape to Define Myeloma — New database might help explain progression and resistance, says Rafael Renatino-Canevarolo, PhD ...

Several recent studies have highlighted the biological complexity of multiple myeloma (MM) that arises as a result of several disrupted cancer pathways. Apart from the central role of genetic ...

The findings contradict previous research suggesting high-risk patients with multiple myeloma were more likely to have a ...

Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the ...

The epigenetic status of the PVR receptor might be a good prognostic marker for multiple myeloma, according to the latest research from the Cancer Epigenetics Lab led by Dr. Manel Esteller at the ...

More information: Laura Martinez-Verbo et al, PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma, Leukemia (2024). DOI: 10.1038/s41375-024-02419-z Journal ...

The molecular pathogenesis of cancers, including multiple myeloma, is deeply related not only to genetic alterations but also to epigenetic changes. The epigenetic regulator KDM5 family proteins are ...

Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the ...